Opinion | Pharma Balancing In The Age Of AI Drug Discovery: Why India Can't Afford To Be A Bystander

If India fails to act now, its $10 billion US market may be the first casualty, but its larger loss will be the claim to be the pharmacy giant of the...

03.10.2025 10

Anusreeta Dutta And Zahid Sultan